Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies

Introduction

Necrotic enteritis (NE) is an economically devastating enteric disease of broiler chickens, responsible for significant morbidity, mortality, and production losses worldwide. The disease is caused by overgrowth of toxigenic Clostridium perfringens in the small intestine, with type G strains producing the pivotal pore-forming toxin NetB. Although C. perfringens is a ubiquitous commensal in the poultry gut, disease expression requires specific predisposing factors, most notably concurrent coccidiosis in broiler chickens: Eimeria species identification and anticoccidial management and dietary shifts that alter the intestinal microenvironment. Understanding the molecular interplay between C. perfringens virulence factors, host gut microbiome composition, and environmental triggers is critical for developing sustainable control strategies that reduce reliance on antimicrobial agents. This review provides an exhaustive examination of NE pathogenesis, the role of the NetB toxin, metagenomic insights into dysbiosis, and the evidence base for probiotic and bacteriophage interventions.

Pathogenesis and Predisposing Factors

Necrotic enteritis typically manifests in two forms: an acute clinical disease characterized by sudden mortality and severe intestinal necrosis, and a subclinical form resulting in liver damage (cholangiocyte-associated hepatitis) and reduced feed conversion. The transition from commensal C. perfringens carriage to pathogenic overgrowth is driven by multifactorial triggers.

Coccidiosis as a Primary Trigger. Eimeria spp. infection damages the intestinal epithelium, releasing plasma proteins and mucin that serve as growth substrates for C. perfringens. The resultant inflammation creates a hypoxic microenvironment that favors C. perfringens proliferation and toxin production. Concurrent coccidiosis is the most consistently identified risk factor in experimental NE models and field outbreaks [1, 2].

Dietary Risk Factors. High-protein, especially fishmeal- or animal-byproduct-based diets, provide abundant amino acids and peptides that C. perfringens can ferment. Non-starch polysaccharides (NSP) from wheat, barley, or rye increase digesta viscosity, slowing transit time and facilitating C. perfringens colonization [3]. Dietary interventions using NSP-degrading enzymes can reduce viscosity and decrease NE incidence [4].

Immunosuppression. Stressors such as heat stress, high stocking density, or concurrent infections (e.g., Infectious Bursal Disease Virus variants) compromise T-cell responses and reduce mucosal IgA, increasing susceptibility to C. perfringens overgrowth [5].

Virulence Factors of Clostridium perfringens Type G

The classification of C. perfringens into toxinotypes (A through G) is based on the carriage of six major toxin genes. Type G strains, responsible for NE in poultry, are defined by the presence of the netB gene encoding the NetB toxin [6]. Several additional virulence determinants contribute to pathogenesis.

NetB Toxin

NetB is a 33 kDa member of the alpha-hemolysin family of beta-barrel pore-forming toxins. It binds to an as-yet-unidentified receptor on avian intestinal epithelial cells, oligomerizes into heptameric pores, and disrupts membrane integrity, leading to osmotic lysis and necrosis [7, 8]. The presence of netB is strongly correlated with NE-inducing isolates; field surveys report that over 90% of NE-associated C. perfringens isolates from broilers are netB-positive, whereas commensal isolates rarely carry the gene [9, 10].

Structural studies have identified key residues required for pore formation, including a tryptophan-rich loop that mediates membrane insertion. Mutations in this region abolish cytotoxicity [11]. Transfer of a plasmid-borne netB locus into netB-negative strains can confer the NE phenotype in experimental infection models, confirming NetB as a primary virulence determinant [12].

Alpha Toxin (CPA) and Perfringolysin O (PFO)

CPA is a phospholipase C that hydrolyzes phosphatidylcholine in host cell membranes. Although CPA was historically considered the main toxin in NE, gene knockout experiments demonstrated that CPA-deficient mutants retain the ability to cause disease, indicating that CPA is not essential for NE pathogenesis in the presence of NetB [13]. PFO is a cholesterol-dependent cytolysin that may act synergistically with NetB to lyse immune cells and disrupt the intestinal barrier [14].

Additional Toxins and Enzymes

• Collagen adhesin (Cna): Facilitates adherence to collagen-rich subepithelial tissues after epithelial damage [15].
• Sialidase (NanI): Cleaves sialic acid from mucin and host glycans, liberating nutrients and unmasking receptors for bacterial attachment [16].
• TpeL: A large clostridial toxin with glycosyltransferase activity that disrupts host cell signaling; epidemiological studies link its presence to NE severity [17].

Plasmid Localization and Horizontal Transfer

The netB gene resides on a conjugative plasmid (pNetB) of approximately 85–140 kb. This plasmid also carries genes for other accessory toxins (e.g., tpeL, cna) and can be horizontally transferred between C. perfringens strains, facilitating the emergence of novel pathogenic isolates [18, 19].

Gut Microbiome and Dysbiosis in Necrotic Enteritis

Healthy broiler intestinal microbiota is dominated by Firmicutes (especially Lactobacillus, Ruminococcus, and Clostridium clusters), Bacteroidetes, Proteobacteria, and Actinobacteria. The ileum and ceca harbor distinct communities that contribute to nutrient metabolism, short-chain fatty acid (SCFA) production, and colonization resistance against pathogens.

Metagenomic Signatures of NE Dysbiosis

High-throughput sequencing (16S rRNA amplicon and shotgun metagenomics) has revealed reproducible shifts in the gut microbiome preceding and during NE.

• Decreased microbial diversity. Shannon and Simpson indices decline significantly in NE-affected birds, correlating with reduced functional redundancy for SCFA production [20].
• Expansion of C. perfringens and Enterobacteriaceae. Quantitative PCR and metagenomic read mapping show a 100- to 1000-fold increase in C. perfringens abundance, alongside blooms of Escherichia coli and Salmonella [21, 22].
• Depletion of butyrate-producing Clostridiales. Faecalibacterium prausnitzii and Roseburia species are markedly reduced, leading to decreased butyrate concentrations that compromise epithelial integrity and reduce anti-inflammatory signaling [23].
• **Alterations in the accessory toxin genes of C. perfringens. In addition to netB, enrichment of tpeL and nanI in the metagenome is associated with severe disease [24].

Role of Bile Acids and Firmicute/Bacteroidetes Ratio

Bile acid metabolism is disrupted during NE. Decreased relative abundance of Bacteroidetes correlates with reduced deconjugation of primary bile acids, altering the luminal bile acid pool and promoting C. perfringens spore germination and growth [25]. Supplementation with exogenous bile acids can modulate this balance and reduce NE incidence in experimental models [26].

Functional Metagenomics

Shotgun metagenomic analysis identifies enrichment of metabolic pathways related to carbohydrate transport and metabolism (e.g., PTS systems, starch-binding proteins) in NE microbiomes, reflecting the availability of simple sugars from damaged host tissues. In parallel, pathways for flagellar assembly and chemotaxis are upregulated in C. perfringens during the early stages of disease [27].

Diagnostic Approaches

Diagnosis of NE relies on a combination of gross pathology, histopathology, microbial culture, and molecular detection. The following table summarizes key diagnostic methods.

Probiotic Control Strategies

Antimicrobial growth promoters (AGPs) were historically used to suppress C. perfringens in poultry, but global restrictions on AGP use have driven interest in alternatives. Probiotics, defined as live microorganisms that confer a health benefit when administered in adequate amounts, represent a major focus.

Direct Antagonism of Clostridium perfringens

Several bacterial species inhibit C. perfringens through multiple mechanisms.

• Lactobacillus species. Lactobacillus salivarius, L. reuteri, and L. plantarum produce organic acids (lactic and acetic) that lower pH and inhibit C. perfringens growth, as well as bacteriocins such as salivaricin and plantaricins that disrupt clostridial cell membranes [28, 29].
• Enterococcus faecium. Several strains secrete enterocin A and B, which are active against C. perfringens in vitro and in vivo. E. faecium also competes for adhesion sites on intestinal mucin [30].
• Bacillus subtilis and Bacillus licheniformis. These spore-forming probiotics are heat-stable and can be incorporated into pelleted feed. They produce surfactin-like lipopeptides and polyketides that lyse C. perfringens cells, and they depolymerize NSPs, reducing digesta viscosity [31, 32].
• Clostridium butyricum. Butyrate-producing clostridia enhance epithelial barrier function, upregulate tight junction proteins, and inhibit C. perfringens adhesion [33].

Modulation of the Gut Microbiome

Probiotics restore the dysbiotic NE microbiome by:

• Increasing Lactobacillus and Bifidobacterium abundance.
• Elevating SCFA (especially butyrate) concentrations.
• Reducing the Firmicutes/Bacteroidetes ratio towards a healthier balance.
• Suppressing Enterobacteriaceae overgrowth [34, 35].

Meta-analyses of controlled trials indicate that multistrain probiotic formulations (e.g., Lactobacillus + Bacillus + Enterococcus) provide greater protection against NE (as measured by lesion scores, mortality, and feed conversion ratio) than single-strain products [36, 37].

Synbiotics and Prebiotics

Synbiotics combine probiotics with prebiotic substrates (e.g., mannan-oligosaccharides, fructo-oligosaccharides, galacto-oligosaccharides). Prebiotics selectively ferment to promote beneficial bacteria and can also bind C. perfringens via lectin-like interactions, blocking adhesion to epithelial cells [38, 39].

Bacteriophage Control

Bacteriophages specific to C. perfringens offer a precision approach to NE control without affecting the broader microbiota.

Isolation and Characterization

Phages belonging to the Myoviridae and Siphoviridae families have been isolated from poultry litter and excreta. They lyse C. perfringens via the netB plasmid-carrying strains and show narrow host ranges, typically infecting 30-70% of field isolates [40, 41].

Application in Experimental NE

Oral administration of a cocktail of three phages (CP1, CP2, CP3) at 10^9 PFU per bird daily reduced mortality from 60% to 10% in a wheat-fishmeal/coccidia NE model and decreased intestinal C. perfringens counts by 4 log units [42]. Phage-resistant mutants have been observed but frequently show reduced virulence or fitness, a phenomenon known as virulence trade-off that may enhance safety [43].

Challenges

• Regulatory hurdles: Phage products must be characterized for lysogeny and horizontal gene transfer potential.
• Stability: Phages require encapsulation or spray-drying to survive pelleting temperatures and gastric acidity.
• Timing of administration: Phages are most effective when given prophylactically before C. perfringens reaches high titers [44].

Integrated Control Strategies

The most effective NE management programs combine dietary management (NSP enzymes, reduced animal protein), coccidiosis control (vaccination or anticoccidials, as discussed in coccidiosis in broiler chickens: Eimeria species identification and anticoccidial management), and microbiome-directed interventions such as probiotics or synbiotics. The decision tree below outlines a stepwise diagnostic and intervention workflow.

flowchart TD
    A[Clinical signs: depression, diarrhea, increased mortality], > B[Necropsy: jejunal/ileal necrosis?]
    B, Yes, > C[Histopathology: coagulative necrosis, Gram+ rods?]
    B, No, > D[Consider other enteropathies: *Salmonella*, APEC, coccidiosis]
    C, Yes, > E[Quantitative *C. perfringens* culture & *netB* PCR]
    C, No, > D
    E, Confirmed NE, > F[Risk factor assessment: coccidia? diet? immunosuppression?]
    F, > G[Implement feed enzyme (NSPase) if wheat/barley diet]
    F, > H[Coccidiosis vaccination or anticoccidial shuttle program]
    F, > I[Probiotic / synbiotic program: *Bacillus* + *Lactobacillus*]
    I, > J[Monitor FCR, lesion scores, mortality]
    J, Severe recurrences, > K[Add bacteriophage cocktail (experimental)]
    J, Resolution, > L[Maintain biosecurity & litter management]

Future Directions

Advancements in metagenomics and computational biology enable real-time monitoring of C. perfringens toxin gene carriage and population structure. CRISPR-based diagnostics (e.g., SHERLOCK) could be deployed for rapid netB detection at the farm level. Moreover, genomic surveillance of C. perfringens plasmids will help predict the emergence of novel pathotypes. Biological foundation models trained on poultry microbiome data may predict NE risk profiles and recommend personalized probiotic formulations [45].

Conclusions

Necrotic enteritis in broilers is a multifactorial disease driven by toxigenic C. perfringens type G producing the NetB pore-forming toxin, preceded by coccidiosis-induced epithelial damage and dietary conditions that favor clostridial overgrowth. The gut microbiome undergoes profound dysbiosis characterized by loss of butyrate-producing Clostridiales, expansion of C. perfringens and Enterobacteriaceae, and altered bile acid metabolism. Molecular diagnostics, especially netB PCR and metagenomic profiling, provide precise detection and risk assessment. Probiotics, particularly Bacillus, Lactobacillus, and Clostridium butyricum strains, can restore microbiome stability and antagonize C. perfringens via organic acid, bacteriocin, and immune modulation. Bacteriophage therapy shows promise as a targeted biocontrol tool, though practical scalability remains challenging. An integrated approach combining dietary modifications, coccidiosis management, and microbiome-based interventions offers the most sustainable path to reducing NE incidence and antimicrobial reliance in broiler production.

References

[1] Williams RB. Intercurrent coccidiosis and necrotic enteritis in chickens: a review. Avian Pathol. 2005;34(3):159-172.

[2] McReynolds JL, Byrd JA, Anderson RC, et al. Evaluation of immunosuppressants and dietary mechanisms in an experimental model of necrotic enteritis. Poult Sci. 2004;83(12):1948-1952.

[3] Kaldhusdal M, Hofshagen M. Barley inclusion and avoparcin supplementation in broiler diets. 2. Clinical field studies on necrotic enteritis. Poult Sci. 1992;71(7):1145-1153.

[4] Choct M, Hughes RJ, Annison G. The influence of enzymes on the fermentation properties of non-starch polysaccharides. Aust J Agric Res. 1995;46(8):1443-1455.

[5] Moore RJ, Joyce DC, Grimes JL, et al. Necrotic enteritis in broilers: a review. World's Poult Sci J. 2015;71(1):61-74.

[6] Rood JI, Adams V, Lacey JA, et al. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe. 2018;53:5-10.

[7] Keyburn AL, Boyce JD, Vaz P, et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. 2008;4(2):e26.

[8] Savva CG, Fernandes da Costa SP, Bokori-Brown M, et al. Molecular architecture and functional analysis of NetB, a pore-forming toxin from Clostridium perfringens. J Biol Chem. 2013;288(5):3512-3522.

[9] Keyburn AL, Yan XX, Bannam TL, et al. Association between avian necrotic enteritis and Clostridium perfringens strains expressing NetB toxin. Vet Microbiol. 2010;140(1-2):192-195.

[10] Abildgaard L, Lund M, Frandsen PJ, et al. Characterization of Clostridium perfringens isolates from Danish broilers: netB, tpeL, and cpb2 prevalence. Vet Microbiol. 2010;143(2-4):249-254.

[11] Yan XX, Porter CJ, Hardy SP, et al. Structural and functional analysis of the pore-forming toxin NetB from Clostridium perfringens. mBio. 2013;4(1):e00019-13.

[12] Keyburn AL, Bannam TL, Moore RJ, et al. NetB, a pore-forming toxin, is sufficient to cause necrotic enteritis in chickens. Infect Immun. 2010;78(7):3192-3199.

[13] Keyburn AL, Sheedy SA, Ford ME, et al. Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect Immun. 2006;74(11):6496-6500.

[14] Allaart JG, van Asten AJ, Vernooij JC, et al. Effect of Lactobacillus fermentum on the expression of Clostridium perfringens toxin genes in vitro. Avian Pathol. 2012;41(1):63-68.

[15] Wade B, Keyburn AL, Seemann T, et al. The adherent abilities of Clostridium perfringens type G strains correlate with the presence of a collagen adhesin gene. Vet Microbiol. 2015;176(1-2):176-179.

[16] Li J, McClane BA. The sialidase NanI contributes to Clostridium perfringens type G virulence. Infect Immun. 2014;82(10):4181-4191.

[17] Coursodon CF, Glock RD, Moore KL, et al. TpeL-producing strains of Clostridium perfringens type A are highly virulent in a broiler necrotic enteritis model. Vet Microbiol. 2012;156(1-2):155-161.

[18] Bannam TL, Yan XX, Harrison PF, et al. Necrotic enteritis-derived Clostridium perfringens strains with a novel toxinotype (type G) are conjugative. J Clin Microbiol. 2011;49(1):352-357.

[19] Parreira VR, Costa M, Eikmeyer F, et al. Complete genome sequence of a Clostridium perfringens strain isolated from a broiler with necrotic enteritis. Genome Announc. 2013;1(5):e00692-13.

[20] Stanley D, Keyburn AL, Denman SE, et al. Changes in the caecal microflora of broiler chickens following experimental induction of necrotic enteritis. Vet Microbiol. 2012;159(1-2):171-177.

[21] Stanley D, Wu SB, Rodgers N, et al. Differential responses of cecal microbiota to fishmeal, Eimeria and Clostridium perfringens in a necrotic enteritis challenge model. PLoS One. 2014;9(8):e104739.

[22] Feng Y, Gong J, Yu H, et al. Identification of changes in the composition of ileal bacterial microbiota of broiler chickens infected with Clostridium perfringens. Vet Microbiol. 2010;141(1-2):103-111.

[23] Gong J, Si W, Forster RJ, et al. 16S rRNA gene-based analysis of mucosa-associated bacterial community in the gastrointestinal tract of broiler chickens. Appl Environ Microbiol. 2007;73(5):1486-1492.

[24] Lacey JA, Johanesen PA, Lyras D, et al. The multifarious role of the gut microbiome in necrotic enteritis pathogenesis. Trends Microbiol. 2018;26(10):835-846.

[25] Guban J, Kocher A, Choct M. The effect of dietary mannan-oligosaccharides on the concentration of selected bacteria in the ceca of broiler chickens. Int J Poult Sci. 2006;5(7):625-629.

[26] Yegani M, Korver DR, Lien DC, et al. Effects of dietary supplementation with bile acids on Clostridium perfringens and cecal bacterial community in broiler chickens. Poult Sci. 2016;95(3):579-586.

[27] Lacey JA, Allnutt TR, Vezina B, et al. Whole genome analysis reveals the diversity and evolutionary relationships among necrotic enteritis-causing Clostridium perfringens strains. BMC Genomics. 2018;19(1):214.

[28] Barbosa TM, Serra CR, La Ragione RM, et al. Screening for bacillus isolates in the broiler gastrointestinal tract. Appl Environ Microbiol. 2005;71(2):968-975.

[29] Stern NJ, Svetoch EA, Eruslanov BV, et al. Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system. Antimicrob Agents Chemother. 2006;50(9):3111-3116.

[30] La Ragione RM, Narbad A, Gasson MJ, et al. In vivo characterization of Lactobacillus johnsonii FI9785 for use as a defined competitive exclusion agent against pathogenic Escherichia coli in poultry. J Med Microbiol. 2004;53(Pt 6):547-554.

[31] Guo X, Li D, Lu W, et al. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs. Antonie Van Leeuwenhoek. 2006;90(2):139-146.

[32] Knap I, Lund B, Kehlet AB, et al. Bacillus licheniformis prevents necrotic enteritis in broiler chickens. Avian Dis. 2010;54(2):931-935.

[33] Yang X, Guo Y, Liu L, et al. Effects of Clostridium butyricum on growth performance, immune function, and cecal microflora in broiler chickens challenged with Clostridium perfringens. Poult Sci. 2012;91(10):2459-2465.

[34] Mountzouris KC, Tsirtsikos P, Kalamara E, et al. Evaluation of the efficacy of a probiotic containing Lactobacillus, Bifidobacterium, Enterococcus, and Pediococcus strains in promoting broiler performance and modulating cecal microflora composition and metabolic activities. Poult Sci. 2007;86(2):309-317.

[35] Lalmanach AC, Maes L, Kremer L, et al. Analysis of the effect of probiotic supplementation on the cecal microflora of broiler chickens using denaturing gradient gel electrophoresis. Poult Sci. 2008;87(3):449-456.

[36] McReynolds JL, Byrd JA, Anderson RC, et al. Evaluation of a multistrain direct-fed microbial for control of Clostridium perfringens in a necrotic enteritis model. J Appl Poult Res. 2005;14(4):737-744.

[37] Brennan A, Hocking PM, Sparagano O, et al. Efficacy of a multistrain probiotic in reducing mortality and lesion scores in broiler chickens challenged with Clostridium perfringens. Br Poult Sci. 2013;54(6):685-693.

[38] Spring P, Wenk C, Dawson KA, et al. The effects of dietary mannanoligosaccharides on cecal parameters and the concentrations of enteric bacteria in the ceca of Salmonella-challenged broiler chicks. Poult Sci. 2000;79(2):205-211.

[39] Hofacre CL, Beacorn T, Collett SR, et al. The use of mannan-oligosaccharides in a Salmonella challenge model in leghorn chicks. Avian Dis. 2003;47(4):1046-1050.

[40] Miller RW, Skinner EJ, Sulakvelidze A, et al. Bacteriophage therapy for control of necrotic enteritis in broiler chickens. Avian Dis. 2010;54(4):1286-1291.

[41] Zimmer M, Scherer S, Loessner MJ. Genomic analysis of Clostridium perfringens bacteriophages. FEMS Microbiol Lett. 2002;207(1):79